ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 94 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $802,000 | +1.6% | 1,228,980 | +69.8% | 0.00% | -50.0% |
Q4 2021 | $789,000 | -25.5% | 723,869 | +24.4% | 0.00% | -33.3% |
Q3 2021 | $1,059,000 | -15.1% | 581,810 | +23.0% | 0.00% | 0.0% |
Q2 2021 | $1,248,000 | +100.6% | 472,895 | +91.5% | 0.00% | +50.0% |
Q4 2020 | $622,000 | +35.8% | 246,960 | +35.9% | 0.00% | 0.0% |
Q3 2020 | $458,000 | +11.4% | 181,657 | +44.9% | 0.00% | 0.0% |
Q2 2020 | $411,000 | +133.5% | 125,387 | +74.5% | 0.00% | +100.0% |
Q1 2020 | $176,000 | -41.5% | 71,848 | +12.5% | 0.00% | -50.0% |
Q4 2019 | $301,000 | +38.7% | 63,861 | +26.2% | 0.00% | 0.0% |
Q3 2019 | $217,000 | +181.8% | 50,596 | +283.3% | 0.00% | +100.0% |
Q2 2019 | $77,000 | – | 13,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |